# Evaluating AlloMax in Immediate Expander-Based Breast Reconstruction Study

> **NCT01372917** · — · COMPLETED · sponsor: **National Center for Plastic Surgery, Virginia** · enrollment: 39 (actual)

## Conditions studied

- Malignant Neoplasm of the Breast
- Acquired Absence of the Breast

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01372917
- **Lead sponsor:** National Center for Plastic Surgery, Virginia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2011-02
- **Final completion:** 2011-08
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2012-06-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01372917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01372917, "Evaluating AlloMax in Immediate Expander-Based Breast Reconstruction Study". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01372917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*